KRAS and pancreatic neoplasm: Moreover, in K-Ras mutant lung adenocarcinoma and pancreatic cancer cell lines, biguanide, in a dose-dependent manner, induced apoptosis and suppressed cell proliferation by targeting crucial downstream effectors of K-Ras signaling such as MAPK and AKT [93].